AL
ALNY icon

Airain Ltd’s Alnylam Pharmaceuticals ALNY Stock Holding History

Airain Ltd’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.14M Buy
+14,306
New +$914K 0.05% 382
2017
Q1 		– Sell
-8,444
Closed -$316K – 786
2016
Q4 		$316K Buy
+8,444
New +$354K 0.03% 487
2015
Q3 		– Sell
-6,576
Closed -$788K – 830
2015
Q2 		$788K Buy
+6,576
New +$786K 0.04% 406
2014
Q2 		– Sell
-20,766
Closed -$1.39M – 754
2014
Q1 		$1.39M Buy
+20,766
New +$1.61M 0.24% 132

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Airain Ltd's ALNY Position: Q2 2017 in Review

Airain Ltd opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2017: 14,306 shares worth $1.14M. The stake represents 0.05% of the portfolio and ranks #382 among its holdings. This is a return to the name: Airain Ltd previously reported a position in ALNY as recently as Q4 2016.

Airain Ltd first reported a position in ALNY in Q1 2014 and has held it in 4 quarters since. The position peaked at $1.39M in Q1 2014. 227 funds tracked by Wall St. Rank hold ALNY as of Q2 2017.

  • Airain Ltd held 14,306 shares of Alnylam Pharmaceuticals worth $1.14M as of Q2 2017.
  • Alnylam Pharmaceuticals was a new Airain Ltd position in Q2 2017.
  • Alnylam Pharmaceuticals made up 0.05% of Airain Ltd's portfolio in Q2 2017, its #382 holding.
  • Airain Ltd first reported a position in Alnylam Pharmaceuticals in Q1 2014 and has held it in 4 quarters since.
  • Airain Ltd's Alnylam Pharmaceuticals position peaked at $1.39M in Q1 2014.
  • 227 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.